INR-based dose adjustment for anticoagulation management
| INR (target 2–3) | Action | Dose Adjustment |
|---|---|---|
| < 1.5 | Subtherapeutic | Increase weekly dose 15–20% |
| 1.5–1.9 | Below target | Increase weekly dose 5–10% |
| 2.0–3.0 | Therapeutic | No change |
| 3.1–3.5 | Supratherapeutic | Decrease weekly dose 5–10% |
| 3.6–4.0 | High | Hold 0–1 dose; decrease 10–15% |
| > 4.0 | Very high / Dangerous | Hold; reassess; vitamin K if indicated |